Articles
Topic

Expected biologic drug approvals in 2025
Antibody-drug conjugates, Biologics, Bispecific antibody, Clinical trials, EMA, FDA, Monoclonal antibody, Vaccines

Biologics CDMO Solutions for the Future of Therapeutics
Biologics, Drug development, Manufacturing

Bioprocess operation modes and advanced bioreactor technology
Cell culture, Drug substance, Manufacturing

Ion exchange chromatography in monoclonal antibodies purification
Analytics, Manufacturing

Enhancing biotechnological research with Design of Experiments
Biostatistics

Quality as the basis for CDMO partnership success
Mabion